Nutra Pharma Corp. NPHC
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Revenue compounded at +37.8% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Not applicable: equity was zero or negative in this period, so return on equity has no meaning.
The 16-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | 0.0 | 0.0 | ◌ | ◌ |
| Net income $B | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.0 | ◌ | ◌ | −0.0 | −0.0 | −0.0 | ◌ | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | 0.00 | 0.00 | 0.00 | 0.00 | −0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.02 | −0.10 | −0.08 | −0.01 | −0.01 | −0.01 | −0.01 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % — not applicable: negative equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares out B | 7.10 | 7.10 | 7.06 | 7.04 | 6.77 | 6.96 | 5.88 | 4.05 | 2.03 | 0.30 | 0.08 | 1.47 | 1.00 | 0.56 | 0.33 | 0.28 |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 12 of the 16 fiscal years we could check. 4 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. Six checks were skipped: the balance sheet is not tagged before 2010. Four checks were skipped: the share count is not tagged before 2011. Three checks were skipped: revenue is not tagged before 2010.